Biohaven Pharmaceuticals, Inc.

This study tested whether adding a new drug called troriluzole could help people with moderate-to-severe OCD whose symptoms weren't fully controlled by their current standard medications. Over 400 participants who were already taking common OCD drugs were randomly assigned to rec…

This study tested whether adding a new drug called troriluzole to a person's current OCD medication could help reduce symptoms better than adding a placebo (a dummy pill). It involved 456 adults whose OCD symptoms were not well-controlled by their standard medication alone. The g…

This study tested whether a drug called troriluzole could help control the symptoms of spinocerebellar ataxia (SCA), a group of rare, inherited disorders that cause worsening problems with coordination and balance. For 8 weeks, 141 adults with SCA received either the drug or a pl…